ANXA8-SP1-PPA1軸をターゲティングして,拡散型胃がんにおけるTCAサイクルとマトリックス収納を調節する
Yuxia Wu1,2, Xiangyan Jiang1,2, Huiguo Qing1,2
1Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Research (Washington, D.C.)
|August 27, 2025
まとめ
研究者らは,TCAサイクルを抑制し,密度の高い細胞外マトリックス (ECM) の堆積を促進することによって,アネキシンA8 (ANXA8) を拡散型胃がん (DGC) の進行の主な原動力として特定した. ANXA8をUNC2025で ターゲットにすると DGCの治療効果が期待できます
科学分野:
- 腫瘍学
- 分子生物学
- 代謝経路
背景:
- 拡散型胃がん (DGC) は攻撃的で,密度の高い細胞外マトリックス (ECM) があり,代謝再プログラムが十分に理解されていない.
- メタボリック再プログラムが腫瘍の進行とECMの堆積に不可欠ですが,規制メカニズムは不明です.
研究 の 目的:
- DGCの代謝シグネチャーを特定し,代謝再プログラムとECMの堆積を結びつける規制メカニズムを解明する.
- DGCの進行におけるアネキシンA8 (ANXA8) の役割とその治療標的としての可能性を調査する.
主な方法:
- 統合された単細胞配列化,タンパク質学,代謝学,および臨床データ
- SP1との相互作用とトリカルボキシル酸 (TCA) 循環の調節を含むANXA8の作用メカニズムを調査した.
- ANXA8阻害 (UNC2025) と5フローロウラシル (5-FU) の併用療法の有効性をテストするために,オルガノイドスクリーニングと患者由来の異種移植を用いた.
主要な成果:
- DGCではトリカルボキシル酸 (TCA) サイクルが抑制され,密度の高いECM形成と相関する.
- ANXA8は,TCAサイクルを阻害し,がんに関連する線維芽細胞を活性化し,ECMの堆積を促進する重要なレギュラーとして特定されました.
- ANXA8の消去は悪性腫瘍を抑制し,UNC2025でANXA8を標的にすると,TCAサイクルの活性が回復し,ECMの堆積が抑制され,5- FUの有効性が強化された.
結論:
- ANXA8によるTCAサイクル抑制は,DGCにおけるECM形成と悪性進行を促します.
- ANXA8を標的にすることは,DGCに対する有望な治療戦略であり,5-FUのような標準化学療法の有効性を高める可能性があります.
- 選択的なANXA8阻害剤であるUNC2025は,特にナノデリバリーシステムを介して投与された場合,重要な治療的可能性を示しています.
さらに関連する動画
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.6K
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
4.5K
関連する概念動画
01:17Gastritis-II: Pathophysiology
543
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
543
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:16Gastric Motility
1.2K
Gastric motility is the coordinated contraction and relaxation of stomach muscles that convert ingested food into chyme, a semi-liquid substance ready for further digestion in the intestines. The process begins with the vagus nerve inducing the relaxation of the smooth muscles in the fundus and body of the stomach, allowing these regions to expand and accommodate up to approximately 1.5 liters of food and liquid.
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
1.2K
01:28Peptic Ulcer Disease II: Pathophysiology
838
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
838
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K